Strategus

FlandersBio on Twitter

Update launch ChondroCelect (Tigenix) and status of reimbursement applications http://tiny.cc/FRRhS

posted 1 day ago

Social Media

Life Sciences Database

in het nederlands

FlandersBio offers an up-to-date life sciences database containing all the life sciences companies with biotech activity in Flanders, and all FlandersBio members. The guide provides easy and fast access to the local life sciences community.

Website: http://www.strategus.be
Email:
Phone: +32 3 235 28 15
Flandersbio Member
More address details

Business Focus

As an independent research & valuation office, we specialize in the valuation of companies, their portfolios and R&D projects. As such we help management to navigate through risks and uncertainties. Since inception we have handled 350 projects in Europe, Asia and the Americas.

Company Profile

Strategus® innovates strategic decision making.
By bridging the gap between finance and strategic decision making, we help management to navigate through uncertainties and complexities, with clear, client-based mathematical models.
Determining the value is one of the keys of success for strategic decision making. Trough the use of our proprietery software, clients can optimize both the development of individual projects, as well as their R&D portfolios.
Our backgrounds are both academic and industrial. They combine investment management, corporate finance, marketing, supply chain management and statistics. We also have extensive experience in the executive management of Life Science companies. All this allows us to offer a balanced, integral approach to any type of valuation. Our senior consultants are CFA and FRM charter holders.

Science & Technology or Services

Strategus® valuation solutions offer management comprehensive answers to a broad range of questions, already in an early stage of the research process.
What is the value of our R&D project at a very early stage? – Which ‘candidate(s)’ from research should we develop ourselves? - What are the best strategic options on a value/ risk base? - Should we make a strategic alliance or proceed alone? - What are valuable partners for research, marketing and distribution? - Should we out-license our product(s) and on which terms? - At what point in time can we choose another route? - What are the optimal outsourcing options according to the different financial characteristics? - What is the best valuation of our company, preparing an IPO? - What is the best financial structure for our company?

In addition to our database, that goes back more than 20 years, we use tailored information on the structure of accomplished deals in the biotech and pharma environment. This answers specific questions: - What is the normal deal structure? - What is a normal royalty rate? - Is a cash payment possible? - Are there any opt-in or opt-out options? - Should we wait to structure the deal? - What alternatives are available?

Alliances

Strategus® clients are operating companies in Life Sciences, financing companies and government agencies. Strategus® has formed partnerships with US and European business development partners.